Olvance M 25 Tablet
Images are for reference. Actual packaging may vary.
Olmesartan Medoxomil (20mg) + Metoprolol Succinate (25mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Olvance M 25 Tablet is a combination antihypertensive medication containing Olmesartan Medoxomil 20 mg and Metoprolol Succinate 25 mg. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, leading to lowered blood pressure. Metoprolol Succinate is a cardioselective beta-1 adrenergic receptor blocker that decreases heart rate, myocardial contractility, and cardiac output, contributing to blood pressure reduction and improved cardiac function.
This combination is indicated for the management of hypertension, particularly in patients who require dual therapy for optimal blood pressure control. Olvance M 25 Tablet helps reduce the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure by effectively controlling elevated blood pressure. It is generally well tolerated; however, caution is advised in patients with bradycardia, heart block, or severe hepatic impairment.
Common adverse effects may include dizziness, fatigue, and hypotension. Olvance M 25 should be used under medical supervision with regular monitoring of blood pressure, renal function, and electrolytes to ensure safety and therapeutic efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olvance M 25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olvance M 25 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Olvance M 25 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olvance M 25 Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Exercise Caution
Olvance M 25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Olvance M 25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Olvance M 25 Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Olvance M 25 Tablet






